HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Armstrong, V. W. Articles by Seidel, D. Search for Related Content PubMed PubMed Citation Articles by Armstrong, V. W. Articles by Seidel, D. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 26, 1314-1323, Copyright © 1985 by Lipid Research, Inc.

ARTICLES

Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a)

VW Armstrong, AK Walli and D Seidel

Treatment of native human Lp(a) under nondenaturing conditions with dithiothreitol yielded both a lipoprotein particle and a lipid-free protein component that could be separated by either ultracentrifugation at d 1.063 g/ml or heparin-Sepharose chromatography. The protein component only showed antigenicity against anti-Lp(a) but not against anti-B. It was heterogeneous according to SDS polyacrylamide gel electrophoresis (PAGE) consisting of two bands, a major band with molecular weight similar to apoB and a minor band with slightly lower molecular weight. The lipoprotein particle was similar to LDL with regard to its electrophoretic mobility, lipid-protein composition, its apparent molecular weight according to gel-exclusion chromatography, and its apoprotein content; only apoB was found to be present by SDS- PAGE and immunochemical analysis. This lipoprotein also proved to be identical to LDL in its uptake by the receptor-mediated LDL-pathway in cultured human fibroblasts as shown by the similarity of the concentration-dependent binding, internalization, and degradation curves at 37 degrees C of the 125I-labeled lipoproteins. Normal Lp(a) was not taken up as readily as either its reduced lipoprotein component or LDL in the various steps of the receptor-mediated pathway. The maximal capacity for Lp(a) in the degradation assay was only 25% of that of LDL and it had a fourfold higher Km. It is therefore probable that the LDL-receptor-mediated pathway is not a major route for the clearance of Lp(a) in vivo. These studies suggest that Lp(a) is, in essence, an LDL-particle to which the protein (a) is attached through disulfide bonds to apoB.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. D Tsironis, J. V Mitsios, H. J Milionis, M. Elisaf, and A. D Tselepis Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase Cardiovasc Res, July 1, 2004; 63(1): 130 - 138. [Abstract] [Full Text] [PDF]

				F. Acquati, R. Hammer, B. Ercoli, V. Mooser, R. Tao, V. Rönicke, A. Michalich, G. Chiesa, R. Taramelli, H. H. Hobbs, et al. Transgenic mice expressing a human apolipoprotein[a] allele J. Lipid Res., June 1, 1999; 40(6): 994 - 1006. [Abstract] [Full Text]

				A. Niemeier, T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 552 - 561. [Abstract] [Full Text] [PDF]

				A. M. Romanic, A. J. Arleth, R. N. Willette, and E. H. Ohlstein Factor XIIIa Cross-links Lipoprotein(a) With Fibrinogen and Is Present in Human Atherosclerotic Lesions Circ. Res., August 10, 1998; 83(3): 264 - 269. [Abstract] [Full Text] [PDF]

				U. Nowak-Gottl, O. Debus, M. Findeisen, R. Kassenbohmer, H. G. Koch, H. Pollmann, C. Postler, P. Weber, and H. Vielhaber Lipoprotein (a): Its Role in Childhood Thromboembolism Pediatrics, June 1, 1997; 99(6): e11 - e11. [Abstract] [Full Text] [PDF]

				J. Pedreno, R. Fernandez, C. Cullare, A. Barcelo, M. A. Elorza, and C. de Castellarnau Platelet Integrin {alpha}IIbß3 (GPIIb-IIIa) Is Not Implicated in the Binding of LDL to Intact Resting Platelets Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 156 - 163. [Abstract] [Full Text]

				K. M. Kostner, G. Maurer, K. Huber, T. Stefenelli, H. Dieplinger, E. Steyrer, and G. M. Kostner Urinary Excretion of Apo(a) Fragments: Role in Apo(a) Catabolism Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 905 - 911. [Abstract] [Full Text]

				F. van Kooten, J. van Krimpen, D. W.J. Dippel, N. Hoogerbrugge, and P. J. Koudstaal Lipoprotein(a) in Patients With Acute Cerebral Ischemia Stroke, July 1, 1996; 27(7): 1231 - 1235. [Abstract] [Full Text]

				R. Carmena, S. Lussier-Cacan, M. Roy, A. Minnich, A. Lingenhel, F. Kronenberg, and J. Davignon Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 129 - 136. [Abstract] [Full Text]

				M. J. Callow and E. M. Rubin Site-specific Mutagenesis Demonstrates That Cysteine 4326 of Apolipoprotein B Is Required for Covalent Linkage with Apolipoprotein(a) in Vivo J. Biol. Chem., October 13, 1995; 270(41): 23914 - 23917. [Abstract] [Full Text] [PDF]

				X. Nogues, M. Seni, J. Pedro-Botet, J. Rubies-Prat, and F. Vidal-Barraquer Serum Lipoprotein (a) Levels in Men with Peripheral Vascular Disease Angiology, August 1, 1991; 42(8): 659 - 664. [Abstract] [PDF]

				G Utermann The mysteries of lipoprotein(a) Science, November 17, 1989; 246(4932): 904 - 910. [Abstract] [PDF]